Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/HUTCHMED-CHINA-LIMITED-59660104/nieuws/HUTCHMED-China-Limited-start-Fase-II-III-studie-van-Sovleplenib-voor-warme-antilichaam-auto-immuun-41978598/?utm_source=whatsapp&utm_medium=social&utm_campaign=share